NESHER TECHNOLOGIES INC

Medtech · Private

Ultrasensitive multiplexed biomarker detection platform using alternating laser excitation (ALEX) single-molecule fluorescence spectroscopy for diabetes diagnostics

Grants
$600K
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · microRNA- and Autoantibody-based Multiplex Assay for Systemic Lupus Erythematosus$150,000
Federal grantDepartment of Health and Human Services · Phase I · microRNA- and Autoantibody-based Multiplex Assay for Systemic Lupus Erythematosus$150,000
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Autoantibody- and microRNA-based Next-Gen Multiplex Test for Type 1 Diabetes$150,000
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Autoantibody- and microRNA-based Next-Gen Multiplex Test for Type 1 Diabetes$150,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
748Endoscopy Assist Devices LLC——
749NVE CORP. (FORMERLY NONVOLATILE ELECTRONICS, INC.——
750PanTher Therapeutics, Inc.—$12M
751NESHER TECHNOLOGIES INC——
752BACKYARD BRAINS, INC.——
753Greppo Technologies LLC——
754SENSEWHY, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Methods And Compositions For Multiplexed And Ultrasensitive Microrna Detectionapplication
  • Methods And Compositions For Multiplexed And Ultrasensitive Microrna Detectionapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.